<--- Back to Details
First PageDocument Content
Medicine / Biotechnology / Kiran Mazumdar-Shaw / Immunology / Humanized antibody / ABLE India / Pharmaceutical industry in India / Biopharmaceutical / Omalizumab / Monoclonal antibodies / Biology / Pharmacology
Date: 2009-11-12 15:50:40
Medicine
Biotechnology
Kiran Mazumdar-Shaw
Immunology
Humanized antibody
ABLE India
Pharmaceutical industry in India
Biopharmaceutical
Omalizumab
Monoclonal antibodies
Biology
Pharmacology

biopulse pagination[removed]04_aw_final for pdf

Add to Reading List

Source URL: www.biocon.com

Download Document from Source Website

File Size: 1,64 MB

Share Document on Facebook

Similar Documents

INDUSTRY ISSUES  What Is a Biopharmaceutical?

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v8Wa - View Document

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

DocID: 1v7ko - View Document

INDUSTRY ISSUES  What Is a Biopharmaceutical?

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v72B - View Document

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

DocID: 1v5W2 - View Document

TERMINOLOGY  What is a Biopharmaceutical?

TERMINOLOGY What is a Biopharmaceutical?

DocID: 1v5mX - View Document